Search Results

With over two decades of pioneering work in upregulating the age-suppressing Klotho gene via stem-cell bioengineering, Dr. Humble brings rigorous science—and real results—to aesthetic medicine.

Galderma, the world’s largest independent dermatology company, announced that it has received antitrust clearance from the U.S. authorities and has completed the acquisition of ALASTIN Skincare®, Inc., a specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed skincare products.

Galderma to Acquire Award-winning ALASTIN Skincare ® Enhancing Its Integrated Dermatology Platform to Continue Delivering the Best Experience to Patients.

ALASTIN Skincare, Inc. announced the first shipment of ALASTIN products into Canada via their partnership with AVARI Medical Ltd.

ALASTIN Skincare ®, Inc. - a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products, announces that the Unit

ALASTIN Skincare®, Inc., a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products, is named the Fastest Growing Brand in the U.S Professional Skincare Market for the third year in a row by consulting and research firm Kline Group’s 2019 Professional Skin Care: U.S. Market Analysis and Opportunities report.

In a strategic move to streamline operations and harness the collective expertise of its team, Crown Laboratories, Inc., a leader in skin science for life, announced the consolidation of its Premium Skincare and Therapeutic business units into a single, robust Consumer Skincare Division.

ALASTIN Skincare®, Inc. - a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products, is pleased to announce the publication of a clinical study highlighting their most recent award-winning breakthrough product, INhance Post-Injection Serum with TriHex Technology®.